Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
Clinical trial NCT02728102 · COMPLETED
Trial details
- NCT number
- NCT02728102
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-06-30
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.